{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:52:15Z","timestamp":1782150735916,"version":"3.54.5"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"vor","delay-in-days":193,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>Rhabdomyolysis associated with the use of pregabalin or azithromycin has been demonstrated to be a rare but potentially life-threatening adverse event. Here, we report an extremely rare case of rhabdomyolysis with purpura in a patient who had used pregabalin and azithromycin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PRESENTATION OF CASE:<\/jats:title>\n                    <jats:p>We present the case of a 75-year-old woman with a history of fibromyalgia who was admitted with mild limb weakness and lower abdominal purpura. She was prescribed pregabalin (75 mg, twice daily) for almost 3 months to treat chronic back pain. Her medical history revealed that 3 days before admission, she began experiencing acute bronchitis and was treated with a single dose of azithromycin (500 mg). She had developed rapid onset severe myalgia, mild whole body edema, muscle weakness leading to gait instability, abdominal purpura and tender purpura on the lower extremities. Laboratory values included a white blood cell count of 25,400\/mL and a creatinine phosphokinase (CPK) concentration of 1250 IU\/L. Based on these findings and the patient\u2019s clinical history, a diagnosis of pregabalin- and azithromycin-induced rhabdomyolysis was made.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>The long-term use of pregabalin and the initiation azithromycin therapy followed by a rapid onset of rhabdomyolysis is indicative of a drug interaction between pregabalin and azithromycin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>We report an extremely rare case of rhabdomyolysis with purpura caused by a drug interaction between pregabalin and azithromycin. However, the mechanisms of the interactions between azithromycin on the pregabalin are still unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T10:09:11Z","timestamp":1468663751000},"page":"221-223","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Pregabalin- and azithromycin-induced rhabdomyolysis with purpura"],"prefix":"10.1097","volume":"26","author":[{"given":"Kazuya","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurina","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-59-20260114","first-page":"907","article-title":"Rhabdomyolysis","volume":"65","author":"Sauret","year":"2002","journal-title":"Am. Fam. Phys"},{"key":"R3-59-20260114","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2009.03473.x","article-title":"Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction","volume":"68","author":"Strandell","year":"2009","journal-title":"Br. J. Clin. Pharmacol"},{"key":"R4-59-20260114","first-page":"624","article-title":"Pregabalin-associated rhabdomyolysis","volume":"199","author":"Gunathilake","year":"2013","journal-title":"MJA"},{"key":"R5-59-20260114","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI Clinical advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J. Am. Coll. Cardiol"},{"key":"R6-59-20260114","first-page":"382","article-title":"Diphosphonate bone scan in an unusal case of rhabdomyolysis: a report and literature review","volume":"20","author":"Ludmer","year":"1993","journal-title":"J. Rheumatol"},{"key":"R7-59-20260114","first-page":"272","article-title":"A review of he literature","volume":"67","author":"Rhabdomyolysis","year":"2009","journal-title":"Neth. J. Med"},{"key":"R8-59-20260114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmaco dynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"William","year":"2002","journal-title":"Clin. Pharmacokeinet"},{"key":"R9-59-20260114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijscr.2015.01.042","article-title":"Pravastatin-induced rhabdomyolysis and purpura fulminans in a patient with chronic renal failure","volume":"8","author":"Kato","year":"2015","journal-title":"Int. J. Surg. Case Rep"},{"key":"R10-59-20260114","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: a common dilemma not reflected in clinical troials","volume":"78","author":"Fernandez","year":"2011","journal-title":"Cleve. Clin. J. Med"},{"key":"R11-59-20260114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2005.01.096","article-title":"Sclerodrma-like changes in cutaneous eruption of rhabdomyolysis","volume":"53","author":"Kim","year":"2005","journal-title":"J. Am. Acad. Dermatol"},{"key":"R12-59-20260114","first-page":"579","article-title":"Pregabalin and simvastatin: first report of a case of rhabdomyolysis","volume":"37","author":"Kaufman","year":"2012","journal-title":"P&T"},{"key":"R13-59-20260114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1345\/aph.1M411","article-title":"Gemfibrozil-induced myositis in a patient with normal renal function","volume":"44","author":"Hahn","year":"2010","journal-title":"Ann. Pharmacother"},{"key":"R14-59-20260114","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"R15-59-20260114","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1096\/fj.07-8713com","article-title":"Rab-small GPTases are involved in fluavastatin and pravastatin-induced vacuolation in rat skeletal myofibers","volume":"21","author":"Sakamoto","year":"2007","journal-title":"FASEB"},{"key":"R16-59-20260114","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta","year":"2004","journal-title":"Circulation"},{"key":"R17-59-20260114","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0091270009352087","article-title":"Clinical pharmacokinetics of pregabalin in healthy volunteers","volume":"50","author":"Bockbrader","year":"2010","journal-title":"J. Clin. Pharmacol"},{"key":"R18-59-20260114","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch. Intern. Med"},{"key":"R19-59-20260114","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003088-200847070-00003","article-title":"Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin","volume":"47","author":"Neuvonen","year":"2008","journal-title":"Clin. Pharmacokinet"},{"key":"R20-59-20260114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000051755","article-title":"Cutaneous eruptions in coma patients with nontraumatic rhabdomyolysis","volume":"203","author":"Miyamoto","year":"2001","journal-title":"Dermatology"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261216302449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261216302449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201626000-00059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:14:40Z","timestamp":1768396480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201626000-00059"}},"subtitle":["An unrecognized interaction A case report"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":19,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2016.07.007","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}